EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice

Masayuki Kuraoka, Clare Burn Aschner, Ian W Windsor, Aakash Mahant Mahant, Scott J Garforth, Susan Luozheng Kong, Jacqueline M Achkar, Steven C Almo, Garnett Kelsoe, Betsy C Herold

Journal of Clinical Investigation · 01.02.2023 · 133 (3)

DOI: 10.1172/jci161968 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.02.2023. Verfasst von Masayuki Kuraoka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Herpes Simplex, Herpesvirus 1, Human. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH NIAID, X-Vax, Technologies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes SimplexHerpesvirus 1, HumanAnimalsHumansMiceAntibodies, NeutralizingAntibodies, ViralGlycoproteinsAntibodies, MonoclonalViral Envelope Proteins

Stichwörter der Autor:innen

AntigenImmunoglobulinsInfectious diseaseVaccines

Substanzen

Antibodies, NeutralizingAntibodies, ViralGlycoproteinsAntibodies, MonoclonalViral Envelope Proteins

Autor:innen und Institutionen

  • Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Microbiology-Immunology, Albert Einstein College of Medicine, New York, New York, USA.
  • Department of Laboratory of Molecular Medicine, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Biochemistry and.
  • Department of Medicine, Albert Einstein College of Medicine, New York, New York, USA.
  • Department of Surgery and.

Förderung

  • NIAID NIH HHS
  • NIH NIAID
  • X-Vax, Technologies

Zitieren

APA

Kuraoka, M., Aschner, C. B., Windsor, I. W., Mahant, A. M., Garforth, S. J., Kong, S. L., Achkar, J. M., Almo, S. C., Kelsoe, G., & Herold, B. C. (2023). A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice. Journal of Clinical Investigation, 133(3). https://doi.org/10.1172/jci161968

Vancouver

Kuraoka M, Aschner CB, Windsor IW, Mahant AM, Garforth SJ, Kong SL, et al. A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice. Journal of Clinical Investigation. 2023;133(3). doi:10.1172/jci161968

BibTeX
@article{Kuraoka2023,
  author = {Kuraoka, Masayuki and Aschner, Clare Burn and Windsor, Ian W and Mahant, Aakash Mahant and Garforth, Scott J and Kong, Susan Luozheng and Achkar, Jacqueline M and Almo, Steven C and Kelsoe, Garnett and Herold, Betsy C},
  title = {A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  volume = {133},
  number = {3},
  doi = {10.1172/jci161968}
}
Kostenlos starten →